Skip to main content
drug protocol number
RJ19/119/J
drug sponsor
King Abdullah International Medical Research Center (KAIMRC)
drug study
BRENTUXIMAB VEDOTIN
drug trial site
King Abdulaziz Medical City NG (Riyadh)
drug status
Rejected
drug phase